J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.
Defining an extended-spectrum β-lactamase
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents 
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Migrant health—a cause for concern?
Defining an extended-spectrum β-lactamase
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.
J.-P. Van geertruyden  Clinical Microbiology and Infection 
O. Clerc, G. Greub  Clinical Microbiology and Infection 
Pseudomonas aeruginosa diversity in distinct paediatric patient groups
Management of post-neurosurgical meningitis: narrative review
Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries  J.A. Otter, N.T. Mutters, E. Tacconelli, A.
A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU  P.G. Higgins, H. Wisplinghoff, O. Krut, H.
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents  S. Brown, S.G.B. Amyes  Clinical.
Louis Pasteur, from crystals of life to vaccination
A.G.G. Lødeng, C. Ahlén, H. Lysvand, L.H. Mandal, O.J. Iversen 
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Escherichia coli native valve endocarditis
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii  M. Bernabeu-Wittel, A. García-Curiel,
Pathophysiology of in-vitro induced filaments, spheroplasts and rod-shaped bacteria in neutropenic mice  J. Buijs, A.S.M. Dofferhoff, J.W. Mouton, J.W.M.
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Vector control: a cornerstone in the malaria elimination campaign
Pharmacodynamics of doxycycline
Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.
Training for the infectious diseases speciality in Norway
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
T.M. File  Clinical Microbiology and Infection 
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Clinical infection services—the Leiden experience
C. Gagliotti, L. Nobilio, M.L. Moro 
Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit  S. Nseir, C. Blazejewski, R. Lubret,
Statin use and clinical outcomes among pneumonia patients
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
O. Clerc, G. Greub  Clinical Microbiology and Infection 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
F.J. Pastor, J. Guarro  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina  S. Uzunovic-Kamberovic,
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory 
Antibiotic overconsumption and resistance in Turkey
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G. Kahlmeter  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Concentration-dependency of β-lactam-induced filament formation in Gram-negative bacteria  J. Buijs, A.S.M. Dofferhoff, J.W. Mouton, J.H.T. Wagenvoort, J.W.M. van der Meer  Clinical Microbiology and Infection  Volume 14, Issue 4, Pages 344-349 (April 2008) DOI: 10.1111/j.1469-0691.2007.01940.x Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Viable counts following incubation of Escherichia coli ATCC 25922 for 4 h in the presence of varying concentrations of ceftazidime or cefotaxime. Clinical Microbiology and Infection 2008 14, 344-349DOI: (10.1111/j.1469-0691.2007.01940.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Examples of morphological experiments showing the appearance (x100) of untreated cells (left), short filaments and long filaments (right) of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii. Clinical Microbiology and Infection 2008 14, 344-349DOI: (10.1111/j.1469-0691.2007.01940.x) Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions